Sirdás sisdollui
  • Universiteahta, allaskuvlla dehe ámmátallaskuvlla dovddaldagaiguin
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
    • Māori
    • தமிழ்
Aiddostahtton
  • Molecular characterization of...
  • Čujuhandieđut
  • Sádde šleađgaboasttain
  • Čálit
  • Doalvvo čujuhusa
    • Doalvun: RefWorks
    • Doalvun: EndNoteWeb
    • Doalvun: EndNote
    • Doalvun: BibTeX
    • Doalvun: RIS
  • Lasit oiddohiidda
  • Bissovaš liŋka
Láddejuvvo…
Bearbmagovva

QR-koda

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Fieke W. Hoff, Ying Huang, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, William G. Blum, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor Kovacsovics, Michael W. Deininger, Joshua F. Zeidner, Rebecca L. Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily K. Curran, Kristin L. Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, John C. Byrd, Yazan F. Madanat
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Nature Publishing Group 2025-04-01
Ráidu:Blood Cancer Journal
Liŋkkat:https://doi.org/10.1038/s41408-025-01258-0
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
  • Oažžasuvvandieđut
  • Govvádus
  • Kommeanttat
  • Ovdageahčadeapmi
  • Geahča maid
  • Bargiidšearbma

Geahča maid

  • Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
    Dahkki: Fieke W. Hoff, et al.
    Almmustuhtton: (2025-04-01)
  • Beat AML genetic risk stratification model in a cohort of older VEN/HMA-treated patients with AML
    Dahkki: Fieke W. Hoff, et al.
    Almmustuhtton: (2025-08-01)
  • Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results
    Dahkki: Michael J. Hochman, et al.
    Almmustuhtton: (2026-04-01)
  • P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS
    Dahkki: Alice Mims, et al.
    Almmustuhtton: (2023-08-01)
  • P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING AGENTS
    Dahkki: Jan Bewersdorf, et al.
    Almmustuhtton: (2023-08-01)

Ozu molssaeavttut

  • Ohcanhistorjá
  • Aiddostahtton ohcu

Viečča lasi

  • Bláđe logahallama
  • Bláđe alfabehtalaš ortnegis
  • Dutkka kanálaid
  • Gursagirjjit
  • Ođatlogahallan

Dárbbašatgo veahki?

  • Ohcanráva
  • Jeara girjerájus
  • DJG:t